Aging and Senescence of Melanocytes

The Pigmentary System: Physiology and Pathophysiology: Second Edition

Volumn , Issue , 2007, Pages 464-471

  Bandyopadhyay, Debdutta ^a   Medrano, Estela E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dihydrofolate reductase; Melanocytes; Metalloproteinases; Thymidilate synthetase; Thymidine kinase

Indexed keywords

EID: 84889615939     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987100.ch23     Document Type: Chapter

References (74)

1. Bandyopadhyay, D., and E. E. Medrano. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p161NK4a/CDK4/pRB and E2F1. Ann. N. Y. Acad. Sci. 908, 71-84, 2000.
2. Bandyopadhyay, D., and E. E. Medrano. The emerging role of epi-genetics in cellular and organismal aging. Exp. Gerontol. 38: 1299-1307, 2003.
3. Bandyopadhyay, D., N. Timchenko, T. Suwa, P. J. Hornsby, J. Campisi, and E. E. Medrano. The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells. Exp. Gerontol. 36:1265-1275, 2001.
4. Bandyopadhyay, D., N. A. Okan, E. Bales, L. Nascimento, P. A. Cole, and E. E. Medrano. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res. 62:6231-6239, 2002.
5. Bastian, B. C. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 22:3081-3086, 2003.
6. Beausejour, C. M., A. Krtolica, F. Galimi, M. Narita, S. W. Lowe, P. Yaswen, and J. Campisi. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22:4212-4222, 2003.
7. Ben Porath, I., and R. A. Weinberg. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113:8-13, 2004.
8. Bennett, D. C., and E. E. Medrano. Molecular regulation of melanocyte senescence. Pigment Cell Res. 15:242-250, 2002.
9. Blasco, M. A. Telomeres in cancer and aging: lessons from the mouse. Cancer Lett. 194:183-188, 2003.
10. Blasco, M. A., H. W. Lee, M. P. Hande, E. Samper, P. M. Lansdorp, R. A. DePinho, and C. W. Greider. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34, 1997.
11. Campisi, J. Replicative senescence: an old lives' tale? Cell 84:497-500, 1996.
12. Campisi, J. The biology of replicative senescence. Eur. J. Cancer 33:703-709, 1997 a.
13. Campisi, J. Aging and cancer: the double-edged sword of replicative senescence. J. Am. Geriatr. Soc. 45:482-488, 1997 b.
14. Campisi, J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:S27-S31, 2001.
15. Campisi, J. Cancer and ageing: rival demons? Nature Rev. Cancer 3:339-349, 2003.
16. Castro, P., D. Giri, D. Lamb, and M. Ittmann. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55: 30-38, 2003.
17. Conlee, J. W., K. J. Abdul-Baqi, G. A. McCandless, and D. J. Creel. Effects of aging on normal hearing loss and noise-induced threshold shift in albino and pigmented guinea pigs. Acta Otolaryngol. 106:64-70, 1988.
18. d'Adda, D. F., P. M. Reaper, L. Clay-Farrace, H. Fiegler, P. T. Carr, von Zglinicki, G. Saretzki, N. P. Carter, and S. P. Jackson. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194-198, 2003.
19. DePinho, R. A. The age of cancer. Nature 408:248-254, 2000.
20. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, and O. Pereira-Smith. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367, 1995.
21. Eisinger, M., and O. Marko. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc. Natl. Acad. Sci. USA 79:2018-2022, 1982.
22. Gilchrest, B. A., F. B. Blog, and G. Szabo. Effects of aging and chronic sun exposure on melanocytes in human skin. J. Invest. Dermatol. 73:141-143, 1979.
23. Gilchrest, B. A., M. A. Vrabel, E. Flynn, and G. Szabo. Selective cultivation of human melanocytes from newborn and adult epidermis. J. Invest. Dermatol. 83:370-376, 1984.
24. Gilhar, A., T. Pillar, M. David, and S. Eidelman. Melanocytes and Langerhans cells in aged versus young skin before and after transplantation onto nude mice. J. Invest. Dermatol. 96:210-214, 1991.
25. Gisselsson, D. Chromosome instability in cancer: how, when, and why? Adv. Cancer Res. 87:1-29, 2003.
26. Govindarajan, B., X. Bai, C. Cohen, H. Zhong, S. Kilroy, G. Louis, M. Moses, and J. L. Arbiser. Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling. J. Biol. Chem. 278:9790-9795, 2003.
27. Greider, C. W. Telomeres and senescence: the history, the experiment, the future. Curr. Biol. 8:R178-R181, 1998.
28. Greider, C. W. Cellular responses to telomere shortening: cellular senescence as a tumor suppressor mechanism. Harvey Lect. 96: 33-50, 2000.
29. Halaban, R., J. S. Rubin, Y. Funasaka, M. Cobb, T. Boulton, D. Faletto, E. Rosen, A. Chan, K. Yoko, and W. White. Met and hepa-tocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2195-2206, 1992.
30. Halaban, R. Responses of cultured melanocytes to defined growth factors. Pigment Cell Res. Suppl. 1:18-26, 1988.
31. Hayflick, L. The limited in vitro lifespan of human diploid cell strains. Exp. Cell Res. 25, 585-621, 1965.
32. Herzberg, A. J., and S. M. Dinehart. Chronologic aging in black skin. Am. J. Dermatopathol. 11:319-328, 1989.
33. Hilding, D. A., and R. D. Ginzberg. Pigmentation of the stria vascularis. The contribution of neural crest melanocytes. Acta Otolaryngol. 84:24-37, 1977.
34. Hornsby, P. J. Cellular senescence and tissue aging in vivo. J. Gerontol. A Biol. Sci. Med. Sci. 57:B251-B256, 2002.
35. Hu, F. Aging of melanocytes. J. Invest. Dermatol. 73:70-79, 1979.
36. Hu, F., K. Mah, and D. J. Teramura. Theophylline effects on normal uveal melanocytes in culture: an ultrastructural study. Pigment Cell Res. 1:104-110, 1987.
37. Jaenisch, R., and A. Bird. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genet. 33 Suppl.:245-254, 2003.
38. Kang, H. L., S. Benzer, and K. T. Min. Life extension in Drosophila by feeding a drug. Proc. Natl. Acad. Sci. USA 99:838-843, 2002.
39. Kimura, T., and K. Doi. Age-related changes in skin color and histologic features of hairless descendants of Mexican hairless dogs. Am. J. Vet. Res. 55:480-486, 1994.
40. Levy, M. Z., R. C. Allsopp, A. B. Futcher, C. W. Greider, and C. B. Harley. Telomere end-replication problem and cell aging. J. Mol. Biol. 225:951-960, 1992.
41. Lim, I. K., H. K. Won, I. H. Kwak, G. Yoon, and S. C. Park. Cytoplasmic retention of p-Erk1/2 and nuclear accumulation of actin proteins during cellular senescence in human diploid fibroblasts. Mech. Ageing Dev 119:113-130, 2000.
42. Lindquist, N. G., B. S. Larsson, J. Stjernschantz, and B. Sjoquist. Age-related melanogenesis in the eye of mice, studied by microautoradiography of 3H-methimazole, a specific marker of melanin synthesis. Exp. Eye Res. 67:259-264, 1998.
43. Liu, Y., K. Z. Guyton, M. Gorospe, Q. Xu, G. C. Kokkonen, Y. D. Mock, G. S. Roth, and N. J. Holbrook. Age-related decline in mitogen-activated protein kinase activity in epidermal growth factor-stimulated rat hepatocytes. J. Biol. Chem. 271:3604-3607, 1996.
44. Medrano, E. E., and J. J. Nordlund. Successful culture of adult human melanocytes obtained from normal and vitiligo donors. J. Invest. Dermatol. 95:441-445, 1990.
45. Medrano, E. E., J. Z. Farooqui, R. E. Boissy, Y. L. Boissy, B. Akadiri, and J. J. Nordlund. Chronic growth stimulation of human adult melanocytes by inflammatory mediators in vitro: implications for nevus formation and initial steps in melanocyte oncogenesis. Proc. Natl. Acad. Sci. USA 90:1790-1794, 1993.
46. Medrano, E. E., F. Yang, R. E. Boissy, J. Z. Farooqui, V. Shah, K. Matsumoto, J. J. Nordlund, and H.-Y. Park. Terminal differentiation and senescence in the human melanocyte: Repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes. Mol. Biol. Cell 5:497-509, 1994.
47. Montagna, W., and K. Carlisle. Structural changes in ageing skin. Br. J. Dermatol. 122 Suppl. 35:61-70, 1990.
48. Narita, M., S. Nunez, E. Heard, M. Narita, A. W. Lin, S. A. Hearn, D. L. Spector, G. J. Hannon, and S. W. Lowe. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:703-716, 2003.
49. Nordlund, J. J. The lives of pigment cells. Dermatol. Clin. 4:407-418, 1986.
50. Ortonne, J. P. Pigmentary changes of the ageing skin. Br. J. Dermatol. 122 Suppl. 35:21-28, 1990.
51. Parrinello, S., E. Samper, A. Krtolica, J. Goldstein, S. Melov, and J. Campisi. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nature Cell Biol. 5:741-747, 2003.
52. Pereira-Smith, O. M., and Y. Ning. Molecular genetic studies of cellular senescence. Exp. Gerontol. 27:519-522, 1992.
53. Rozanowska, M., W. Korytowski, B. Rozanowski, C. Skumatz, M. E. Boulton, J. M. Burke, and T. Sarna. Photoreactivity of aged human RPE melanosomes: a comparison with lipofuscin. Invest. Ophthalmol. Vis. Sci. 43:2088-2096, 2002.
54. Sarna, T., J. M. Burke, W. Korytowski, M. Rozanowska, C. M. Skumatz, A. Zareba, and M. Zareba. Loss of melanin from human RPE with aging: possible role of melanin photooxidation. Exp. Eye Res. 76:89-98, 2003.
55. Satyamoorthy, K., G. Li, M. R. Gerrero, M. S. Brose, P. Volpe, B. L. Weber, P. Van Belle, D. E. Elder, and M. Herlyn. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res. 63:756-759, 2003.
56. Schwahn, D. J., W. Xu, A. B. Herrin, E. S. Bales, and E. E. Medrano. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation. Pigment Cell Res. 14, 32-39, 2001.
57. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677, 1996.
58. Sherr, C. J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689-3695, 2000.
59. Sherr, C. J., and J. M. Roberts. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512, 1999.
60. Smith, J. R., and O. M. Pereira-Smith. Replicative senescence: implications for in vivo aging and tumor suppression. Science 273, 63-67, 1996.
61. Steingrimsson, E., K. J. Moore, M. L. Lamoreux, A. R. Ferre-D'Amare, S. K. Burley, D. C. Zimring, L. C. Skow, C. A. Hodgkinson, H. Arnheiter, and N. G. Copeland. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nature Genet. 8:256-263, 1994.
62. Sviderskaya, E. V., S. P. Hill, T. J. Evans-Whipp, L. Chin, S. J. Orlow, D. J. Easty, S. C. Cheong, D. Beach, R. A. DePinho, and D. C. Bennett. p16(Ink4a) in melanocyte senescence and differentiation. J. Natl. Cancer Inst. 94:446-454, 2002.
63. Sviderskaya, E. V., V. C. Gray-Schopfer, S. P. Hill, N. P. Smit, T. J. Evans-Whipp, J. Bond, L. Hill, V. Bataille, G. Peters, D. Kipling, D. Wynford-Thomas, and D.C. Bennett. p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apopto-sis, and immortalization: possible implications for melanoma progression. J. Natl. Cancer Inst. 95:723-732, 2003.
64. Swope, V. B., E. E. Medrano, D. Smalara, and Z. A. Abdel-Malek. Long-term proliferation of human melanocytes is supported by the physiologic mitogens alpha-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp. Cell Res. 217:453-459, 1995.
65. Takada, K., K. Sugiyama, I. Yamamoto, K. Oba, and T. Takeuchi. Presence of amelanotic melanocytes within the outer root sheath in senile white hair. J. Invest Dermatol. 99:629-633, 1992.
66. Tassabehji, M., V. E. Newton, and A. P. Read. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nature Genet. 8:251-255, 1994.
67. Tobin, D. J., and R. Paus. Graying: gerontobiology of the hair follicle pigmentary unit. Exp. Gerontol. 36:29-54, 2001.
68. Torres, C., M. K. Francis, A. Lorenzini, M. Tresini, and V. J. Cristofalo. Metabolic stabilization of MAP kinase phosphatase-2 in senescence of human fibroblasts. Exp. Cell Res. 290:195-206, 2003.
69. Tuveson, D. A., B. L. Weber, and M. Herlyn. BRAF as a potential therapeutic target in melanoma and other malignancies. Cancer Cell 4:95-98, 2003.
70. von Zglinicki, T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 27:339-344, 2002.
71. von Zglinicki, T. Replicative senescence and the art of counting. Exp. Gerontol. 38:1259-1264, 2003.
72. von Zglinicki, T., J. Petrie, and T. B. Kirkwood. Telomere-driven replicative senescence is a stress response. Nature Biotechnol. 21:229-230, 2003.
73. Wright, W. E., and J. W. Shay. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11:98-103, 2001.
74. Wright, W. E., and J. W. Shay. Historical claims and current interpretations of replicative aging. Nature Biotechnol. 20:682-688, 2002.